ABL001 – a new BCR-ABL inhibitor for chronic myeloid leukemia (CML) treatment
Oncogenic mutational networks in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)
New drug targets for AML
Ibrutinib in diffuse large B-cell lymphoma
Inherited and acquired genetic factors involved in the development of CLL
John Gribben et al.